Delivery Order SPE2DB22D1103-SPE2DB25FTDH7

Award Date 12/23/24
Potential Completion Date 12/24/24
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB22D1103
    Indefinite Delivery Contract
  • SPE2DB22D1103-SPE2DB25FTDH7
    Delivery Order

This federal contract award, valued at $1,043.27, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that supports military healthcare programs globally. The awarded contract covers the supply of an estrogen-methyltestosterone medication for a period ending on December 24, 2024. This award is not designated as a set-aside contract, indicating open competition. Amerisourcebergen, as the prime contractor, will be responsible for providing the requested pharmaceutical product to meet the medical needs of the military and other federal beneficiaries through the DLA's contracting mechanism.

Generated 3/24/25, 9:48 AM